What is the ticker symbol for AgeX Therapeutics?

AgeX Therapeutics trades under the ticker AGE on AMEX.

What sector does AgeX Therapeutics operate in?

AgeX Therapeutics is classified in the Healthcare sector (Biotechnology industry).

How can PortView help analyze AGE in a portfolio?

PortView shows AGE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

AgeX Therapeutics (AGE) Stock Analysis

AMEXHealthcareBiotechnology

$11.10-11.90%

1-year price historyRange $11.10 – $31.41

52-week range$11.10

$10.90$35.17

What AgeX Therapeutics does

AgeX Therapeutics, Inc. is a U.S.-based biotechnology company dedicated to pioneering and commercializing groundbreaking therapies that address human aging and degenerative conditions. The company's developmental pipeline features several promising cell-based therapeutic candidates: AGEX-BAT1: A cell therapy designed to manage various age-related metabolic disorders, including adult-onset Type II diabetes and obesity. AGEX-VASC1: A cell-based approach aimed at re-establishing vital vascular support in aged ischemic tissues, which could be relevant for conditions such as peripheral vascular disease and ischemic heart disease. Beyond cell therapies, AgeX is also exploring other modalities: Its primary drug candidate in the discovery phase is AGEX-iTR1547, a drug formulation focused on achieving scarless wound repair. For induced tissue regeneration, its leading biologic candidate is AGEX-iTR1550, which leverages gene delivery technology. Furthermore, AgeX maintains a research collaboration with the University of California at Irvine, jointly working to develop cellular therapies for various neurological disorders. Founded in 2017, AgeX Therapeutics, Inc. maintains its headquarters in Alameda, California.

Key metrics

Market cap

$27.76M

P/E (TTM)

-0.02

EPS (TTM)

$-482.53

Beta

1.19

Dividend yield

0.00%

Revenue / share

$0.00

50-day avg

$13.98

200-day avg

$19.89

52-week high

$35.17

52-week low

$10.90

CEO

Eun-Jae Park CPA

ETFs linked to AGE

Broad-market and Healthcare sector ETFs an investor holding AgeX Therapeutics is often also exposed to. Open an ETF page to see its actual top holdings.

SPY — SPDR S&P 500 ETF Trust VOO — Vanguard S&P 500 ETF QQQ — Invesco QQQ Trust VTI — Vanguard Total Stock Market ETF

PortView Portfolio Insights

PortView analyzes how AGE fits your actual portfolio — position weight, portfolio concentration, unrealized gain/loss, contribution to return, sector exposure, indirect exposure through the ETFs you hold, and correlation with your other holdings. Connect a portfolio to see your personalized figures; PortView never shows another user's private holdings.

Analyze AGE in PortView →

Similar companies

JNJ — Johnson &LLY — Eli Lilly A — Agilent Technologies ABBV — AbbVie Inc.ABT — Abbott Laboratories ALNY — Alnylam Pharmaceuticals

Frequently asked questions

What is the ticker symbol for AgeX Therapeutics?: AgeX Therapeutics trades under the ticker AGE on AMEX.
Which exchange is AGE listed on?: AGE is listed on AMEX.
What sector does AgeX Therapeutics operate in?: AgeX Therapeutics is classified in the Healthcare sector (Biotechnology industry).
How can PortView help analyze AGE in a portfolio?: PortView shows AGE's weight in your portfolio, its contribution to return and risk, sector exposure, indirect exposure through ETFs you own, and correlation with your other holdings.

The information provided by PortView is for informational and educational purposes only and does not constitute investment advice. Market data may be delayed. Past performance does not guarantee future results.